ACE and Ascites: Intake of diuretics and angiotensin-converting-enzyme inhibitors/angiotensin-1-receptor blockers (ACEi/ARB) was unequally distributed throughout the strata of PH and hepatic dysfunction, as patients with ascites are usually treated with diuretics, while ACEi/ARB are discontinued due to the risk of acute kidney injury.